Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 151-200 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07046936
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
N/ARecruiting
30 participants
Started: Nov 30, 2025 · Completed: Apr 30, 2027
1 condition1 sponsor2 locations
NCT06769165
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
NARecruiting
20 participants
Started: Nov 30, 2025 · Completed: Aug 1, 2026
1 condition1 sponsor1 location
NCT06930625
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
PHASE3Recruiting
119 participants
Started: Nov 30, 2025 · Completed: Mar 31, 2029
1 condition1 sponsor32 locations
NCT07206056
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
PHASE1/PHASE2Recruiting
188 participants
Started: Nov 28, 2025 · Completed: Dec 17, 2030
1 condition1 sponsor2 locations
NCT07194070
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
N/ARecruiting
175 participants
Started: Nov 28, 2025 · Completed: Sep 30, 2030
1 condition1 sponsor3 locations
NCT05558709
Social-cognitive Functioning: Validation of a New Neuropsychological Test
NARecruiting
120 participants
Started: Nov 28, 2025 · Completed: Nov 28, 2029
3 conditions1 sponsor1 location
NCT06728098
Safety and Tolerability Evaluation of Akkermansia Muciniphila
NARecruiting
108 participants
Started: Nov 25, 2025 · Completed: Mar 25, 2026
1 condition1 sponsor1 location
NCT07165054
Periodontal Pathogens and Atherom Plaque The Number of Mitochondrial DNA Copies
N/ARecruiting
55 participants
Started: Nov 25, 2025 · Completed: Dec 1, 2026
4 conditions1 sponsor1 location
NCT06681818
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
NARecruiting
125 participants
Started: Nov 21, 2025 · Completed: Jan 1, 2039
2 conditions1 sponsor1 location
NCT06863909
Study on the Effectiveness of Journaling As an Add-on to Cognitive Behavioral Therapy
NARecruiting
80 participants
Started: Nov 20, 2025 · Completed: Dec 31, 2026
7 conditions1 sponsor1 location
NCT07199465
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
PHASE1Recruiting
40 participants
Started: Nov 19, 2025 · Completed: May 19, 2028
1 condition1 sponsor1 location
NCT06609343
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
PHASE1/PHASE2Recruiting
16 participants
Started: Nov 18, 2025 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT06434064
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
PHASE2Recruiting
30 participants
Started: Nov 15, 2025 · Completed: Nov 30, 2028
4 conditions1 sponsor1 location
NCT06817889
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
PHASE2Recruiting
60 participants
Started: Nov 15, 2025 · Completed: Nov 30, 2027
4 conditions2 sponsors3 locations
NCT07023627
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
PHASE2Recruiting
160 participants
Started: Nov 15, 2025 · Completed: Oct 24, 2027
1 condition2 sponsors82 locations
NCT07219095
Dance Mental Health App
NARecruiting
50 participants
Started: Nov 15, 2025 · Completed: Nov 15, 2029
3 conditions2 sponsors1 location
NCT06999811
Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
NARecruiting
37 participants
Started: Nov 15, 2025 · Completed: Oct 15, 2028
2 conditions2 sponsors1 location
NCT06835049
Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
PHASE2Recruiting
24 participants
Started: Nov 15, 2025 · Completed: Mar 31, 2031
1 condition1 sponsor8 locations
NCT06948786
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
PHASE2Recruiting
22 participants
Started: Nov 14, 2025 · Completed: Jul 31, 2031
5 conditions2 sponsors1 location
NCT07150806
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
PHASE1/PHASE2Recruiting
30 participants
Started: Nov 13, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06936059
A PRPCT to Assess the Efficacy & Safety of Chronic Pain Rehab Training Software for Alleviating Chronic Secondary Musculoskeletal Pain
NARecruiting
80 participants
Started: Nov 12, 2025 · Completed: Nov 12, 2026
1 condition1 sponsor1 location
NCT06983899
Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial
NARecruiting
100 participants
Started: Nov 11, 2025 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT07076121
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
PHASE2/PHASE3Recruiting
470 participants
Started: Nov 3, 2025 · Completed: May 3, 2029
1 condition1 sponsor269 locations
NCT07102082
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
NARecruiting
160 participants
Started: Nov 1, 2025 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT06575075
Pilot Study of RR-HNK in OCD
PHASE1/PHASE2Recruiting
45 participants
Started: Nov 1, 2025 · Completed: Nov 30, 2029
1 condition2 sponsors1 location
NCT06906562
A Phase II Nationwide, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
PHASE2Recruiting
40 participants
Started: Nov 1, 2025 · Completed: Dec 31, 2026
5 conditions2 sponsors71 locations
NCT03629977
Timing of Renal Replacement Therapy in the Critically Ill Patients
N/ARecruiting
50,000 participants
Started: Nov 1, 2025 · Completed: Apr 1, 2027
5 conditions1 sponsor1 location
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
PHASE3Recruiting
750 participants
Started: Nov 1, 2025 · Completed: Aug 30, 2032
1 condition1 sponsor4 locations
NCT07217236
Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG
NARecruiting
11,492 participants
Started: Nov 1, 2025 · Completed: Oct 31, 2026
3 conditions1 sponsor1 location
NCT07217405
Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis
PHASE4Recruiting
165 participants
Started: Nov 1, 2025 · Completed: Oct 1, 2027
2 conditions1 sponsor1 location
NCT07217535
Rutgers University Study of the Genetics of Kidney Disease
N/ARecruiting
50,000 participants
Started: Nov 1, 2025 · Completed: Oct 31, 2027
6 conditions2 sponsors1 location
NCT06902246
Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma
PHASE2Recruiting
30 participants
Started: Nov 1, 2025 · Completed: Nov 1, 2030
2 conditions2 sponsors1 location
NCT06587256
Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.
PHASE2Recruiting
100 participants
Started: Nov 1, 2025 · Completed: Oct 31, 2029
2 conditions1 sponsor1 location
NCT07050173
Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation
PHASE1Recruiting
30 participants
Started: Nov 1, 2025 · Completed: Dec 27, 2027
1 condition2 sponsors1 location
NCT07218276
Passive Robots for Stroke Rehabilitation: A Feasibility Study
NARecruiting
4 participants
Started: Nov 1, 2025 · Completed: Oct 1, 2027
1 condition1 sponsor1 location
NCT07220356
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
PHASE4Recruiting
30 participants
Started: Nov 1, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06952998
Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease
PHASE4Recruiting
38 participants
Started: Nov 1, 2025 · Completed: May 30, 2027
1 condition2 sponsors1 location
NCT06941324
Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors
NARecruiting
60 participants
Started: Nov 1, 2025 · Completed: May 1, 2027
2 conditions2 sponsors1 location
NCT06782542
Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy
PHASE2Recruiting
16 participants
Started: Nov 1, 2025 · Completed: Nov 1, 2028
2 conditions2 sponsors1 location
NCT07092280
Transcranial Direct Current Stimulation in Children With Autism
NARecruiting
24 participants
Started: Nov 1, 2025 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT07107139
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
NARecruiting
50 participants
Started: Nov 1, 2025 · Completed: Mar 1, 2027
1 condition2 sponsors1 location
NCT07052630
Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial
NARecruiting
40 participants
Started: Nov 1, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT07077005
Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy
NARecruiting
24 participants
Started: Nov 1, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT07213986
Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction
NARecruiting
12 participants
Started: Nov 1, 2025 · Completed: Mar 1, 2026
2 conditions2 sponsors1 location
NCT06260891
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
PHASE2Recruiting
34 participants
Started: Nov 1, 2025 · Completed: Dec 31, 2027
1 condition8 sponsors1 location
NCT07098364
ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma
PHASE1/PHASE2Recruiting
33 participants
Started: Nov 1, 2025 · Completed: Oct 4, 2043
12 conditions2 sponsors1 location
NCT07095933
The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
EARLY_PHASE1Recruiting
5 participants
Started: Nov 1, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT07161661
Chronic Low Back Pain and Osteopathic Manipulation Treatment
NARecruiting
48 participants
Started: Nov 1, 2025 · Completed: Aug 31, 2027
2 conditions2 sponsors1 location
NCT06741072
BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
PHASE1Recruiting
55 participants
Started: Nov 1, 2025 · Completed: Dec 31, 2027
5 conditions1 sponsor1 location
NCT07210437
Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI
NARecruiting
18 participants
Started: Nov 1, 2025 · Completed: Jun 1, 2028
1 condition2 sponsors1 location